Mavacamten in Patients with Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results from the VALOR-HCM Randomized Clinical Trial
Milind Y. Desai*, Anjali Owens, Kathy Wolski, Jeffrey B. Geske, Sara Saberi, Andrew Wang, Mark Sherrid, Paul C. Cremer, Neal K. Lakdawala, Albree Tower-Rader, David Fermin, Srihari S. Naidu, Nicholas G. Smedira, Hartzell Schaff, Ellen McErlean, Christina Sewell, Lana Mudarris, Zhiqun Gong, Kathy Lampl, Amy J. SehnertSteven E. Nissen
Dive into the research topics of 'Mavacamten in Patients with Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results from the VALOR-HCM Randomized Clinical Trial'. Together they form a unique fingerprint.